FDA 510(k)

VITEK 2 AST-诱导克林霉素耐药性链球菌

K号: K260282 · 2026-04-15

决定日期2026-04-15

产品代码LON

咨询委员会抱歉，您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is the device name listed in this FDA 510(k) record. The listed applicant is bioMerieux, Inc.. It received FDA 510(k) clearance on 2026-04-15 under 510(k) number K260282. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is a medical device that received FDA 510(k) clearance on 2026-04-15. The listed applicant is bioMerieux, Inc.. The 510(k) number is K260282.

When did VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance receive FDA 510(k) clearance?

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance received FDA 510(k) clearance on 2026-04-15, under 510(k) number K260282.

Who is the listed applicant for VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

The FDA 510(k) record lists bioMerieux, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

The FDA product code for VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is LON.

列明bioMerieux, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K260160VITEK REVEAL GN AST 测定和 VITEK REVEAL AST 系统 K251579VITEK 2 AST-革兰氏阴性头孢唑啉（=<1-=>32 µg/mL）K234012VITEK COMPACT PRO K232967VITEK 2 AST-酵母伏立康唑（<= 0.03125 - >= 4 µg/mL）K232963VITEK 2 AST-酵母阿尼鲁兰（<= 0.015 - >= 8 µg/mL）K240279VIDAS TBI（GFAP，UCH-L1）

查看所有 65 个设备 →

相关器械（代码：LON）

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K260281VITEK 2 AST-链球菌头孢呋辛（<=0.125 - >=8 µg/mL）BIOMERIEUX K251579VITEK 2 AST-革兰氏阴性头孢唑啉（=<1-=>32 µg/mL）bioMerieux, Inc.K251713BD Phoenix 自动微生物学系统 - GN 恩拉韦环素（0.125-2 µg/mL）Becton, Dickinson and Company K250447BD Phoenix® 自动微生物学系统 - GN 亚胺培南-雷巴匹坦（0.0625/4 - 16/4 µg/mL）Becton, Dickinson and Company K234012VITEK COMPACT PRObioMerieux, Inc.K250344BD Phoenix® 自动微生物学系统Becton, Dickinson and Company

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。